Web View
Guidance leaps, filings slip
Miyakoshi lifted revenue guidance 75%; Abalance pushed results to late August as an Abit probe widened. Japanese filings were in a mood to remind readers that timing matters.
MARKETS
Market pulse
Tokyo equities softened while the 10Y JGB yield nudged lower.
Sourced from Nikkei, JPX, BOJ, MOF - values, not commentary.
lead
The calendar slips
Abalance shifts results to late August as Abit probe prompts filing-extension plan
A June 30 probe into accounting and suspicious transactions at former subsidiary Abit has pushed Abalance's results to late August, while a separate U.S. solar-shipment dispute leaves another ¥3bn to ¥5bn potential hit to be settled in the same window.
secondary
Capital, strategy and the confidence trade
Miyakoshi flips to projected profit as semiconductor orders top plan
The move: Miyakoshi lifted its revenue forecast 75% to ¥3.5bn and now expects ¥150mn of operating profit after saying memory-chip procurement talks and large Japanese sales negotiations moved ahead.
Kansai Paint sets ¥10bn buyback, with 5mn-share cap and planned cancellation
Up to 5mn shares, or 2.81% of stock, can be repurchased between August 2026 and August 2027, and Kansai Paint says the shares bought will be cancelled, though market conditions could prevent full execution.
Ise Chemical secures US brine rights, targets 3,000 tonnes of iodine output by 2030
The Japanese producer will fund the plant build-out itself under a 10-year deal with Select Water Solutions, aiming to establish a new US iodine supply source and reach about 3,000 tonnes a year from the project by 2030.
Nippon Sheet Glass shareholders approve restructuring steps tied to tentative November delisting
The vote passed the authorized-share increase, share consolidation, share-unit rule changes and six-director slate behind a capital restructuring whose October and November milestones remain provisional pending competition, foreign-investment and Foreign Subsidies Regulation procedures.
secondary
Earnings worth a second look
DCM keeps annual targets after first-quarter operating profit rises 17%
The move: DCM's operating profit rose 17.4% to ¥11.4bn in the three months to May 31, while revenue increased 9.8% to ¥151.9bn. Management left its full-year profit target at ¥31.2bn and its annual dividend forecast at ¥48 a share.
Toyota Industries sales rose to ¥4.37tn, but operating profit was weakest in its five-year summary
Revenue extended a five-year climb, but operating profit dropped to ¥137.0bn from ¥221.7bn as parent profit eased and total assets reached ¥11.19tn.
Buffalo sales fell, but earnings and cash held up
Sales dropped to ¥117.31bn in the year to March, but Buffalo still lifted ordinary income to ¥10.22bn and closed the year with a 60.0% equity ratio and ¥27.22bn in cash.
quick hits
Quick Hits
Tsumura adds COO Kei Sugii as representative director
Read moreThe June 26 appointment took effect immediately and leaves Sugii running the Prescription Kampo Medicine Company, with Tsumura saying it wants a stronger management structure and faster decisions.
Japan health ministry clarifies pharmacy reward rules and flags cashback via prescription sites
Read moreThe ministry says pharmacies that add their own rewards on top of card-payment points must explain that total benefits on insured dispensing copayments stay within 1%, and it separately makes cashback routed through prescription-reception sites an oral-guidance target.
Nissan Tokyo Sales says Nissan Motor, not its direct 38% holder, has greatest influence
Read moreThe dealer group says Nissan matters most because it wholly owns the company holding 38% of voting rights and supplies its main products, while the filing lays out ¥52.5bn of vehicle purchases and lease obligations tied to Nissan-group property.
Hokuryo lifts annual dividend to ¥130 after ¥3.86bn net profit
Read moreThe egg producer reported ¥23.11bn in sales and ¥3.86bn in net income for the year to March, while raising its annual dividend to ¥130 a share from ¥70.